Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.
in Mar 20, 2023
March 20 2023 at 8:00 am – March 22 at 5:00 pm – UTC+0
Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.
in Feb 01, 2023
February 6 2023 at 8:00 am – February 7 at 5:00 pm – UTC+0
Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023
in Dec 11, 2022
January 9 2023 at 8:00 am – January 12 at 5:00 pm – UTC+0
Purple Biotech to participate and Present at the Jefferies London Healthcare Conference
in Nov 11, 2022
November 15 2022 at 8:00 am – November 17 at 5:00 pm – UTC+0
Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis
in Nov 08, 2022
November 14 2022 at 8:00 am – November 17 at 5:00 pm – UTC+0
Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. – Click here to replay
in Nov 01, 2022
November 8 2022 at 8:00 am – 5:00 pm – UTC+0
Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022 annual meeting
in May 29, 2022
June 5 2022 at 11:00 am – 11:00 am – UTC+0
Purple Biotech to present at the AACR annual meeting 2022
in Apr 07, 2022
April 8 2022 at 8:00 am – 5:00 pm – UTC+0
Purple Biotech to participate in a Fireside Chat at BTIG Virtual Biotechnology Conference
in Jul 29, 2021
August 9 2021 at 8:00 am – August 10 at 5:30 pm – UTC+0
Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Annual Meeting
in Jun 02, 2021
June 4 2021 at 12:00 am – June 8 at 11:59 pm – UTC+0